These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32074200)

  • 1. Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes.
    Souza TMB; Cerqueira AMS; Suerdieck JG; Sá NC; Sodré GS; Correia VCA; Lacerda YF; Fonseca LL; Noya-Rabelo MM; Correia LCL
    Arq Bras Cardiol; 2020 Apr; 114(4):666-672. PubMed ID: 32074200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
    Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
    Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
    Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.
    Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
    Almeida R; Mariano L; Gavina C; Pinho T; Vasconcelos M; Ferreira A; Maciel MJ; Gonçalves FR
    Rev Port Cardiol; 2006 Jan; 25(1):71-5. PubMed ID: 16623357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndrome in patients with cancer: features of the course and the possibility of predicting hospital and long-term (6 months) periods using GDF-15, NT-proBNP, hs-CRP biomarkers.
    Shalenkova MA; Ivanov AV; Klimkin PF
    Kardiologiia; 2021 Oct; 61(10):4-13. PubMed ID: 34763634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
    Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
    Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study.
    Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E
    Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
    Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
    Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.